Levers of von Willebrand factor, type 1 plasminogen activator inhibitor and adiponectin in coronary heart disease patients with hyperglycemia
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To investigate the levels of von Willebrand factor(vWF),type 1 plasminogen activator inhibitor(PAI-1) and adiponectin in coronary heart disease patients with hyperglycemia.Methods Oral glucose tolerance test was carried out in the patients with coronary heart disease and different abnormal glucose metabolism,including diabetes mellitus(DM,n=44,26.99%),impaired glucose tolerance(IGT,n=59,24.38%),impaired fasting glucose(n=15,7.46%);and 40 patients(24.54%)with normal glucose tolerance(NGT) as the control group.The level of vWF,PAI-1 and adiponectin was measured by ELISA for all these patients.Results vWF level increased in DM and IGT groups compared with NGT group,and showed significant statistical signiticance;PAI-1 level increased in DM group with statistical significance;adiponectin level of IGT and DM groups was higher than that of NGT group,and showed significant statistical signiticance.Conclusion Hyperglycemia causes high vWF and PAI-1 level,low adiponectin level,and leads to severe endothelial lesion.It is essential to discover and control hyperglycemia as early as possible to prevent the onset and development of coronary heart disease.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online:
  • Published:
Article QR Code